Edgewise Therapeutics Inc. Common Stock vs Rollins Inc. Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $38.27 (market cap $4.02B), while Rollins Inc. Common Stock trades at $33.85 (market cap $15.70B). The key difference: Rollins Inc. Common Stock is far larger — about 3.9× Edgewise Therapeutics Inc. Common Stock's market cap, and Rollins Inc. Common Stock pays a 2.24% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Rollins Inc. Common Stock for 0 Days on average.
| EWTX | ROL | |
|---|---|---|
Market Cap | $4.02B | $15.70B |
Volume | 1,446,128 | 4,855,082 |
Sector | Health | Industrials |
52-Week High | $48.35 | $65.60 |
52-Week Low | $14.89 | $29.69 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.56B | $16.71B |
Dividend Yield | — | 2.24% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →Rollins Inc. provides pest control services to residential and commercial customers through its family of brands, including Orkin, across dozens of countries.
Read more on ROL →